Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.5M Buy
27,256
+617
+2% +$72.2K 0.53% 34
2026
Q1
$3.2M Sell
26,639
-946
-3% -$109K 0.57% 35
2025
Q4
$2.9M Sell
27,585
-585
-2% -$54.9K 0.51% 39
2025
Q3
$2.36M Sell
28,170
-2,808
-9% -$231K 0.43% 47
2025
Q2
$2.45M Buy
30,978
+1,650
+6% +$131K 0.48% 44
2025
Q1
$2.63M Sell
29,328
-3,407
-10% -$318K 0.57% 42
2024
Q4
$3.26M Sell
32,735
-1,267
-4% -$131K 0.68% 38
2024
Q3
$3.86M Sell
34,002
-1,659
-5% -$197K 0.79% 33
2024
Q2
$4.41M Sell
35,661
-234
-0.7% -$30.1K 0.99% 24
2024
Q1
$4.74M Sell
35,895
-475
-1% -$58.5K 1.09% 21
2023
Q4
$3.97M Buy
36,370
+3,454
+10% +$359K 0.99% 25
2023
Q3
$3.39M Buy
32,916
+2,132
+7% +$230K 0.95% 30
2023
Q2
$3.55M Sell
30,784
-738
-2% -$83.8K 0.99% 28
2023
Q1
$3.5M Hold
31,522
1.06% 28
2022
Q4
$3.5M Sell
31,522
-333
-1% -$34K 1.06% 28
2022
Q3
$2.74M Sell
31,855
-654
-2% -$58.4K 0.9% 36
2022
Q2
$2.96M Buy
32,509
+482
+2% +$42.7K 0.92% 36
2022
Q1
$2.63M Buy
32,027
+3,126
+11% +$246K 0.71% 47
2021
Q4
$2.21M Buy
28,901
+1,895
+7% +$151K 0.59% 54
2021
Q3
$2.03M Buy
+27,006
New +$2.05M 0.56% 56

Other funds holding MRK

Essex LLC's MRK Position: Q2 2026 in Review

Essex LLC increased its Merck (MRK) stake by 2.3% in Q2 2026, buying an estimated $72.2K and bringing the position to 27,256 shares worth $3.5M. The position accounts for 0.53% of the portfolio, ranked #34.

Essex LLC first reported a position in MRK in Q3 2021 and has held it in 20 quarters since. The position peaked at $4.74M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Essex LLC held 27,256 shares of Merck worth $3.5M as of Q2 2026.
  • Essex LLC bought 617 Merck shares in Q2 2026, an estimated $72.2K.
  • Merck made up 0.53% of Essex LLC's portfolio in Q2 2026, its #34 holding.
  • Essex LLC first reported a position in Merck in Q3 2021 and has held it in 20 quarters since.
  • Essex LLC's Merck position peaked at $4.74M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Essex LLC's 13F filing for Q2 2026, filed 24 Jul 2026.